Bora Pharma partners with TaiRx to manufacture breakthrough anticancer drug in Taiwan

Drug Discovery |  News | 0 Comment | 26 Sep, 2022

Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a Tai...Read more

Huawei Cloud's Pangu drug molecule model accelerates new drug discovery

Drug Discovery |  News | 0 Comment | 19 Sep, 2022

On September 19, HUAWEI CONNECT 2022 kicked off in Bangkok, Thailand. At the event, Ken Hu, Rotating and Actin...Read more

Innovent Biologics, Sanofi to develop cancer medicines for China

Drug Discovery |  News | 0 Comment | 05 Aug, 2022

Innovent Biologics and Sanofi have announced a collaboration to bring innovative medicines to patients in China with dif...Read more

Sosei Heptares and AbbVie enter new multi-target collaboration worth $1.2 B

Drug Discovery |  News | 0 Comment | 03 Aug, 2022

Japanese firm Sosei Group Corporation and US-based AbbVie, a research-based global biopharmaceutical company, have enter...Read more

Singapore develops new compounds to kill multi drug-resistant TB

Drug Discovery |  News | 0 Comment | 04 Aug, 2022

With multi drug-resistant tuberculosis (TB) causing outbreaks in both developing and developed nations, new treatments a...Read more

Singapore develops drug molecule for treating atrial fibrillation

Drug Discovery |  News | 0 Comment | 18 Jul, 2022

Scientists from the National University of Singapore (NUS) Department of Pharmacy have developed an improved pharmaceuti...Read more

Japanese startup Elix introduces 'all-in-one' platform for AI drug discovery

Drug Discovery |  News | 0 Comment | 15 Jul, 2022

Japan-based startup Elix, Inc., an artificial intelligenet (AI) drug discovery company with the mission of “Rethin...Read more

Singapore approves GSK's new cancer therapy for ovarian cancer

Drug Discovery |  News | 0 Comment | 04 Jul, 2022

GlaxoSmithKline (GSK) Singapore has announced that Health Sciences Authority has approved Zejula&nbs...Read more

Eurofins DiscoverX expands APAC operations with new biotech office in China

Drug Discovery |  News | 0 Comment | 04 Jul, 2022

Eurofins DiscoverX Products LLC, a global industry leader in products for small and large molecule drug discovery a...Read more

Korean startups ILIAS Biologics and HK inno.N join hands for new biomedicines

Drug Discovery |  News | 0 Comment | 06 Jun, 2022

South Korean startup ILIAS Biologics has signed a Memorandum of Understanding (MoU) with HK inno.N for joint research to...Read more

Japanese startup LUCA Science raises $30.3 M in Series B funding

Drug Discovery |  News | 0 Comment | 06 Jun, 2022

Japan-based startup LUCA Science, a global innovator in the development of a novel class of mitochondria biopharmaceutic...Read more

Standigm signs MOU with Merck Korea for AI drug discovery research

Drug Discovery |  News | 0 Comment | 02 Jun, 2022

South Korea-based startup Standigm Inc. has announced the signing of a Memorandum of Understanding (MoU) with Merck Kore...Read more

China's Zelixir Biotech predicts monkeypox protein structures for drug discovery

Drug Discovery |  News | 0 Comment | 31 May, 2022

Zelixir Biotech, based in China, has predicted more than 600 structures and added functional annotations of proteins fro...Read more

Insilico Medicine explores use of 3CL protease inhibitor for COVID-19 treatment

Drug Discovery |  News | 0 Comment | 25 May, 2022

Insilico Medicine, a China & US-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery c...Read more

Japanese firms initiate joint research on next-gen IT drug discovery technology

Drug Discovery |  News | 0 Comment | 17 May, 2022

Japan-based Fujitsu and RIKEN have launched a joint research project on next-generation IT drug discovery technology uti...Read more

University of Tokyo, Astellas further advance development of innovative medicines

Drug Discovery |  News | 0 Comment | 27 Apr, 2022

The University of Tokyo and Astellas Pharma Inc., in Japan, have entered the second phase of their collaboration for co-...Read more

FDA grants Fast Track designation for Paradigm Biopharmaceuticals Phase III Osteoarthritis Program

Drug Discovery |  News | 0 Comment | 14 Apr, 2022

Australia's Paradigm Biopharmaceuticals, a clinical stage biopharmaceutical company focused on repurposing existing...Read more

TauRx's late-stage clinical trial reaches new milestone

Drug Discovery |  News | 0 Comment | 14 Apr, 2022

TauRx Pharmaceuticals Ltd, a global leader in tau-based Alzheimer's Disease (AD) research, has announced that the last p...Read more